Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is ‘exceedingly effective’ at preventing the disease in mice. [s]Science Daily[/s] reports that according to Dr Yukai He, immunologist at the [b]Medical College of Georgia[/b] and [b]Georgia Regents University Cancer Centre[/b], patients typically have surgery to remove the diseased portion of the liver, but there are currently no effective adjuvant therapies, such as chemotherapy, to reduce recurrence. He says ideally, some version of his vaccine will one day provide that key missing piece and dramatically improve patient survival.
[link url=http://www.sciencedaily.com/releases/2014/06/140603092535.htm]Full Science Daily report[/link]
[link url=http://onlinelibrary.wiley.com/doi/10.1002/hep.26893/abstract;jsessionid=B113C5E05EB6B9D6326AD059B087FCBC.f03t03]Hepatology abstract[/link]